Mary Klotman, MD, Dean of the School of Medicine shared the following announcement with the School of Medicine faculty:
It is with great sadness that we write to inform you that Mark Feinglos, MD, passed away on March 14, 2020.
Dr. Feinglos was a Professor of Medicine and an Associate Professor of Psychiatry and Behavioral Sciences and of Pathology. Feinglos served as chief of the Division of Endocrinology, Metabolism, and Nutrition in the Department of Medicine from 2000 to 2012. Under his leadership, faculty in the division doubled in numbers and the fellowship program became one of the strongest in the country.
Feinglos called Duke home for nearly 50 years. He completed his residency and fellowship here after receiving his medical degree from McGill University in Canada and he joined the Duke faculty in 1978.
He was a highly respected and accomplished physician-scientist. Feinglos was principal investigator (PI) or co-PI on multiple grants and author on more than 150 publications. His research interests focused on etiology and the treatment of type 2 diabetes mellitus. He studied the role of the autonomic nervous system in the pathophysiology of type 2 diabetes in humans and the mechanism of action of dietary therapy and a variety of pharmacological agents in the treatment of type 2 diabetes.
Feinglos was also a mineral collector specializing in Tsumeb minerals, found at the Tsumeb mine in Namibia. He was the first to discover a mineral, which is now named feinglosite in his honor.
Please join us in extending our deepest condolences to Dr. Feinglos’ family and friends.